- Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
- Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!
Reply to: BOOM: Covid Vaccine Number 2
Collapse
You are not logged in or you do not have permission to access this page. This could be due to one of several reasons:
- You are not logged in. If you are already registered, fill in the form below to log in, or follow the "Sign Up" link to register a new account.
- You may not have sufficient privileges to access this page. Are you trying to edit someone else's post, access administrative features or some other privileged system?
- If you are trying to post, the administrator may have disabled your account, or it may be awaiting activation.
Logging in...
Previously on "BOOM: Covid Vaccine Number 2"
Collapse
-
Damn, see I would feel really reluctant to take a vaccine that has been tested on 5 people. I thought maybe a trial would be a few hundred? Maybe a thousand?
I had no idea that gave it to 15,000 people as a test! That's a bit more reassuring. Thanks for the link.
Leave a comment:
-
Originally posted by FIERCE TANK BATTLE View PostI'm no maths genius, but 94.5% effacacy would mean 4.725 people didn't get the 'rona after taking it, wouldn't it?
How'd they figure that out?
The trial involved 30,000 people in the US with half being given two doses of the vaccine, four weeks apart. The rest had dummy injections.
The analysis was based on the first 95 to develop Covid-19 symptoms.
Only five of the Covid cases were in people given the vaccine, 90 were in those given the dummy treatment. The company says the vaccine is protecting 94.5% of people.
The data also shows there were 11 cases of severe Covid in the trial, but none happened in people who were immunised.
Leave a comment:
-
Originally posted by jayn200 View PostTo get the exact figure you'd have to know how many participants in each group, it might not be the same. I haven't seen how many, not sure if that information is out there.
https://techcrunch.com/2020/11/16/mo...rXwIMpzY53ChRy
Leave a comment:
-
Originally posted by FIERCE TANK BATTLE View PostI'm no maths genius, but 94.5% effacacy would mean 4.725 people didn't get the 'rona after taking it, wouldn't it?
How'd they figure that out?
Leave a comment:
-
Originally posted by NickFitz View PostApparently Matt Hancock said several months ago that there was no need to order any of this one because the government would do a much better job of creating a vaccine anyway, or something equally dumb
Leave a comment:
-
Apparently Matt Hancock said several months ago that there was no need to order any of this one because the government would do a much better job of creating a vaccine anyway, or something equally dumb
Leave a comment:
-
Originally posted by SueEllen View PostAn interim analysis released on Monday, and based on 95 patients with confirmed Covid infections, found the candidate vaccine has an efficacy of 94.5%. The company said it now plans to apply to the US regulator, the Food and Drug Administration, for emergency-use authorisation in the coming weeks. In the trial, 90 of the patients received the placebo with the remaining five the vaccine.
How'd they figure that out?
Leave a comment:
-
this is what has been ordered:
100m doses of University of Oxford/AstraZeneca vaccine (in phase 3 clinical trials)40m doses of BioNTech/Pfizer vaccine (in phase 3 clinical trials)
60m doses of Novavax vaccine (in phase 3 clinical trials)
60m doses of Valneva vaccine (in pre-clinical trials)
60m doses of GSK/Sanofi Pasteur vaccine (in phase 1 clinical trials)
30m doses of Janssen vaccine (in phase 2 clinical trials)
Leave a comment:
-
I just wonder how much the US general public will have to pay to be vaccinated.
Leave a comment:
- Home
- News & Features
- First Timers
- IR35 / S660 / BN66
- Employee Benefit Trusts
- Agency Workers Regulations
- MSC Legislation
- Limited Companies
- Dividends
- Umbrella Company
- VAT / Flat Rate VAT
- Job News & Guides
- Money News & Guides
- Guide to Contracts
- Successful Contracting
- Contracting Overseas
- Contractor Calculators
- MVL
- Contractor Expenses
Advertisers
Contractor Services
CUK News
- Secondary NI threshold sinking to £5,000: a limited company director’s explainer Dec 24 09:51
- Reeves sets Spring Statement 2025 for March 26th Dec 23 09:18
- Spot the hidden contractor Dec 20 10:43
- Accounting for Contractors Dec 19 15:30
- Chartered Accountants with MarchMutual Dec 19 15:05
- Chartered Accountants with March Mutual Dec 19 15:05
- Chartered Accountants Dec 19 15:05
- Unfairly barred from contracting? Petrofac just paid the price Dec 19 09:43
- An IR35 case law look back: contractor must-knows for 2025-26 Dec 18 09:30
- A contractor’s Autumn Budget financial review Dec 17 10:59
Leave a comment: